In Vitro Diagnostics Market Research Reports & Industry Analysis
In Vitro Diagnostics Industry Research & Market Reports
-
Genetic Toxicology Testing Market Size, Share & Trends Analysis Report By Type (In Vitro, In Vivo), By Product (Reagents & Consumables, Assays Kit, Services), By Assay, By Application, By Region, And Segment Forecasts, 2024 - 2030
... 2030 Genetic Toxicology Testing Market Growth & Trends The global genetic toxicology testing market size is anticipated to reach USD 3.57 billion by 2030, registering to grow at a CAGR of 11.6% from 2024 to ... Read More
-
Clinical Chemistry Market
... 2024 to USD 21.46 billion by 2032, exhibiting a CAGR of 5.4% during the forecast period of 2023-2032. Due to the covid pandemic many companies shut down their prediction units and projects due to hindered ... Read More
-
Point of Care Data Management Software
... the year 2023, is expected to reach US$2.0 Billion by 2030, growing at a CAGR of 10.2% over the analysis period 2023-2030. On-Premise Deployment, one of the segments analyzed in the report, is expected to ... Read More
-
Bio-MEMS Devices
... at a CAGR of 16.7% over the analysis period 2023-2030. Implantables, one of the segments analyzed in the report, is expected to record a 15.6% CAGR and reach US$18.2 Billion by the end of the ... Read More
-
Blood Culture Tests
... by 2030, growing at a CAGR of 6.0% over the analysis period 2023-2030. Conventional Tests, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$4.3 Billion by ... Read More
-
Cell Counting
... at a CAGR of 5.3% over the analysis period 2023-2030. Cell Counting Consumables, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$12.9 Billion by the end ... Read More
-
Cell Viability Assays
... by 2030, growing at a CAGR of 7.1% over the analysis period 2023-2030. Consumables Component, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$5.3 Billion by ... Read More
-
Cell Signaling
... at a CAGR of 5.4% over the analysis period 2023-2030. Consumables Component, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$4.5 Billion by the end of ... Read More
-
Fertility Testing
... at a CAGR of 6.3% over the analysis period 2023-2030. Ovulation Predictor Kits, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$571.1 Million by the end ... Read More
-
Sepsis Diagnostics
... at a CAGR of 7.5% over the analysis period 2023-2030. Microbiology Technology, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$749.8 Million by the end of ... Read More
-
Slide Stainers
... at a CAGR of 9.6% over the analysis period 2023-2030. Slide Stainer Reagents, one of the segments analyzed in the report, is expected to record a 10.8% CAGR and reach US$6.4 Billion by the end ... Read More
-
Microfluidics
... of 16.1% over the analysis period 2023-2030. Microfluidics Devices, one of the segments analyzed in the report, is expected to record a 14.5% CAGR and reach US$63.5 Billion by the end of the analysis period. ... Read More
-
Service Laboratories
... at a CAGR of 4.4% over the analysis period 2023-2030. The U.S. Market is Estimated at US$29.5 Billion While China is Forecast to Grow at 4.1% CAGR The Service Laboratories market in the U.S. is ... Read More
-
Enteric Disease Testing
... by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. Bacterial Enteric Disease Testing, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$1.8 ... Read More
-
Blood Transfusion Devices
... by 2030, growing at a CAGR of 5.7% over the analysis period 2023-2030. Pathogen Reduction System, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$3.7 Billion ... Read More
-
Cell Proliferation Kits
... by 2030, growing at a CAGR of 5.5% over the analysis period 2023-2030. Pharma & Biotech Companies End-Use, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach ... Read More
-
Cervical Cancer Diagnostic Testing
... reach US$10.6 Billion by 2030, growing at a CAGR of 5.1% over the analysis period 2023-2030. Pap Smear Test, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and ... Read More
-
Mice Model
... at a CAGR of 5.2% over the analysis period 2023-2030. CRISPR / CAS9 Technology, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$976.7 Million by the ... Read More
-
Flow Chemistry
... at a CAGR of 8.9% over the analysis period 2023-2030. Chemicals Application, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$1.1 Billion by the end of ... Read More
-
Fertility Services
... at a CAGR of 14.9% over the analysis period 2023-2030. Fresh Non-Donor Services, one of the segments analyzed in the report, is expected to record a 16.1% CAGR and reach US$75.3 Billion by the end ... Read More
-
Women`s Health Diagnostics
... by 2030, growing at a CAGR of 5.7% over the analysis period 2023-2030. Breast Cancer Testing Application, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$11.3 ... Read More
-
Cancer Diagnostics
... at a CAGR of 5.7% over the analysis period 2023-2030. Breast Application, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$56.4 Billion by the end of ... Read More
-
Carrier Screening
... at a CAGR of 15.7% over the analysis period 2023-2030. Genetic Disorders, one of the segments analyzed in the report, is expected to record a 18.8% CAGR and reach US$3.0 Billion by the end of ... Read More
-
Cell Isolation / Cell Separation
... is expected to reach US$42.8 Billion by 2030, growing at a CAGR of 16.7% over the analysis period 2023-2030. Consumables Component, one of the segments analyzed in the report, is expected to record a 19.5% ... Read More
-
Blood Screening
... at a CAGR of 5.6% over the analysis period 2023-2030. Nucleic Acid Test (NAT), one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$1.7 Billion by the ... Read More
Research Assistance
